Ligand profile
ML2
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_2684 — ribosyldihydronicotinamide dehydrogenase (quinone)
Identifiers
Database identifiers and provenance.
- Ligand ID
ML2- PDB
2qx8- UniProt (similar protein)
P16083- Target protein
- VK055_2684
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 54.1
- −1 ≤ LogP ≤ 5 2.46
- MW ≤ 500 Da 358.2
- LogP ≤ 5 2.46
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 54.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=O)NCCc1c2cc(ccc2[nH]c1I)OCCC(=O)NCCc1c2cc(ccc2[nH]c1I)OC
InChI=1S/C13H15IN2O2/c1-8(17)15-6-5-10-11-7-9(18-2)3-4-12(11)16-13(10)14/h3-4,7,16H,5-6H2,1-2H3,(H,15,17)InChI=1S/C13H15IN2O2/c1-8(17)15-6-5-10-11-7-9(18-2)3-4-12(11)16-13(10)14/h3-4,7,16H,5-6H2,1-2H3,(H,15,17)
FJDDSMSDZHURBJ-UHFFFAOYSA-NFJDDSMSDZHURBJ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02525
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand ML2 →
- PDB RCSB structure 2qx8 →
- UniProt UniProt P16083 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ML2”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2684.
PDB 59
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).